On the recordMarch 28, 2012
There is going to be on our part the need for an unprecedented level of oversight, transparency, and accountability as part of these reauthorizations.
Source
congress.govEditor's note · Context
Burr emphasizes the need for oversight in user fee reauthorizations.
Share & report
More from Richard Burr
Sep 14, 2022
Madam President, it is clearly apparent by listening to this debate, if Senator Sanders had been on the PEB board, the PEB board wouldn't be making a recommendation and the President wouldn't be behind it. But that is where we are, short…
Mar 21, 2022
We have offered a lot of plans up here that you can't figure it out until you have already passed it, what it is going to cost.
Jun 15, 2022
I will continue to ask you for a plan until we get one, and I will continue to be a roadblock for those who believe that we can blindly just appropriate emergency money.
Apr 4, 2022
What does it mean for a small company when FDA misses these goals, and what does it mean to patients?
Other voices in this conversation
